Skip to main content
OpenTrials
Completed

NCT Number: NCT04146532

Aspirin Effects on Emotional Reactions

The aim of this study is to determine whether the drug aspirin has effects on emotional reactivity, emotional memory, and risk-taking behaviors.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Early Phase 1

Primary location

Psychology Building

Columbus, Ohio, 43210, United States

About this study

The goal of this study is to determine if aspirin (acetylsalicylic acid) alters emotional reactions to emotion evoking pictures as well as memory for them. Using a double-blind parallel arm study, participants will receive either placebo or a pain-relieving dose of aspirin (500mg). One hour later they will complete 30 minutes of tasks. This will include ratings of emotional pictures and memory for them. The paradigm is similar to previous experiments done in this lab using other cyclooxygenase inhibitors: ibuprofen and acetaminophen (Durso, Luttrell, & Way, 2015; Psychological Science, https://doi.org/10.1177/0956797615570366). Risk taking on the Balloon Analogue Risk Task will also be assessed. Participants will be healthy young adult males at Ohio State University.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

At least 18 years old and biologically male

Exclusion criteria

Due to the use of aspirin in this study, women will be excluded from the study due to potential negative effects it may have on pregnancy

Participants will also be excluded for the following medical reasons:

  • Having an allergy to aspirin, other salicylates, or any other pain reliever/fever reducer.
  • Having or recovering from a viral infection such as the chicken pox or flu.
  • Having taken aspirin or another NSAID drug (aspirin, ibuprofen, naproxen, or others) within the last 8 hours or plan to take aspirin or another NSAID drug in the 8 hours after the end of the study.
  • Having more than three drinks of alcohol in the 8 hours after completion of the study.
  • Having asthma, hay fever, nasal polyps, or chronic respiratory disease.
  • Impaired liver/kidney or impaired cardiovascular circulation (renal vascular disease, congestive heart failure, volume depletion, major surgery, sepsis or major hemorrhagic events)
  • Active or severe liver or kidney disease.
  • An ulcer, history of ulcers or are prone to bleeding.
  • A history of blood clotting defects.
  • Severe anemia.
  • Taking any of the following drugs: A blood thinning anticoagulant (e.g. warfarin), Digoxin, An Angiotensin Converting Enzyme (ACE) Inhibitor, Methotrexate, An oral glucocorticoid (e.g. hydrocortisone),Valproic Acid, A Selective Serotonin Reuptake Inhibitor (SSRI; e.g. Prozac; Zoloft)
  • Have had stomach ulcers or bleeding problems.
  • Have stomach problems such as heartburn, upset stomach, or stomach pain that does not go away or reoccurs.
  • Surgery in the last week or will have a surgery in the next week.
  • High blood pressure.
  • Diabetes, gout, or arthritis.
  • Low uric acid or Glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Treatment and study plan

Aspirin 500 MG

Drug

Single 500mg aspirin capsule.

Other names: actelysalicylic acid

Placebo

Drug

Single 500mg placebo capsule.

Primary outcomes

  1. Emotional Reactivity

    Time frame: 1.5 hours

    Changes in self-reported evaluations of valence on a 1 to 7 scale and felt reactions to emotional images on a 1-7 scale.

  2. Memory

    Time frame: 1.5 hours

    Changes in memory for emotional pictures. After rating the images, the participants will be shown them again as well as new pictures and asked to indicate whether they have seen the picture before or not.

  3. Risk-Taking

    Time frame: 1.5 hours

    We will measure the adjusted average number of pumps on the Balloon Analogue Risk Task.

Secondary outcomes

  1. Individual Differences

    Time frame: 1.5 hours

    Self-reported political ideology will be examined as a moderator of the self-reported ratings of the images as well as memory for them.

Sponsors and collaborators

Lead sponsor

Ohio State University

Other

Registry information

Official study title

Effects of Aspirin on Emotional Reactivity, Memory, and Risk-taking

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Oct 31, 2019
Registry last updated
Jun 3, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.